Objective: A strong genetic predisposition for type 2 diabetes mellitus (T2DM) may aggravate the negative effects of low socioeconomic position (SEP) in the etiology of the disorder. This study aimed to examine cross-sectional and longitudinal associations and interactions of a genetic risk score (GRS) and SEP with T2DM and to investigate whether clinical and behavioral risk factors can explain these associations and interactions. Methods: We used data from 13,027 genotyped participants from the Lifelines study. The GRS was based on single-nucleotide polymorphisms genome-wide associated with T2DM and was categorized into tertiles. SEP was measured as educational level. T2DM was based on biological markers, recorded medication use, and self-reports. Cross-sectional and longitudinal associations and interactions between the GRS and SEP on T2DM were examined. Results: The combination of a high GRS and low SEP had the strongest association with T2DM in cross-sectional (odds ratio = 3.84, 95% confidence interval = 2.28-6.46) and longitudinal analyses (hazard ratio = 2.71, 1.39-5.27), compared with a low GRS and high SEP. Interaction between a high GRS and a low SEP was observed in cross-sectional (relative excess risk due to interaction = 1.85, 0.65-3.05) but not in longitudinal analyses. Clinical and behavioral risk factors mostly explained the observed associations and interactions. Conclusions: A high GRS combined with a low SEP provides the highest risk for T2DM. These factors also exacerbated each other's impact cross-sectionally but not longitudinally. Preventive measures should target individual and contextual factors of this high-risk group to reduce the risk of T2DM.
INTRODUCTION
T ype 2 diabetes mellitus (T2DM) is a common chronic health condition affecting hundreds of millions of people worldwide (1) . In 2014, the estimated global prevalence was 9.0% for adult men and 7.9% for adult women (1) . T2DM results in a high number of disability-adjusted life years and is a major risk factor for other diseases such as cardiovascular disease and chronic kidney disease (2) (3) (4) (5) . Evidence on T2DM is extensive but is still lacking on the interaction between genetic and environmental factors in the etiology of the disease. This evidence is essential to successfully tackle this major public health problem.
Low socioeconomic position (SEP) is a well-known risk factor for T2DM (6) . A systematic review and meta-analysis, including 23 studies with 41 measures of association between low SEP and T2DM incidence, found that low SEP, measured as low educational level, low occupational status, and low income, was associated with increased relative risks for T2DM in high-, middle-, and low-income countries (6) . The association between low SEP and T2DM is probably due to a high prevalence of clinical and behavioral risk factors, such as obesity and physical inactivity, among people with a low SEP (7-10) often in co-occurrence (11) (12) (13) . These risk factors are potentially modifiable.
Genetic and environmental factors have been shown to interact in the etiology of T2DM (14) . Regarding SEP and genetic predisposition, one might expect that the negative effects of low SEP on T2DM are aggravated by a strong genetic predisposition through the interplay of genetics and environmental risk factors associated with low SEP (15) . This genetic predisposition can be operationalized as a genetic risk score (GRS), which takes into account all single-nucleotide polymorphisms (SNPs) associated with T2DM (16) . If people are not genetically predisposed to the disease, i.e., in case of a low GRS, low SEP may have little or no effect.
To our knowledge, only one study investigated the interaction between a GRS and SEP regarding T2DM (15) . This study showed that the effect of strong genetic predisposition on glycated hemoglobin (HbA1c) levels was smaller among people with a higher educational level (15) . Studies on specific behavioral and clinical risk factors showed that obesity and a Western dietary pattern (i.e., high intake of red and processed meats and refined foods) interact with genetic predisposition in the etiology of T2DM (17) (18) (19) . However, evidence lacks on the influence of genetic predisposition on the overarching effect of low SEP in the etiology of T2DM.
The aggravating or buffering effect of a strong or weak genetic predisposition on the effect of low SEP in the etiology of T2DM may also differ by sex, e.g., because of differences in metabolic homeostasis (20) . It was previously found that family history of T2DM and low SEP exacerbated each other's impact in females but not in males (21) . Because possible sex differences may be important for the design of future prevention and intervention strategies, they need to be taken into account.
Therefore, the main aims of this study are to examine associations and interactions of a GRS and SEP with T2DM and to investigate whether clinical and behavioral risk factors can explain these associations and interactions. Possible effect modification by sex will be taken into account in the analyses. We will perform crosssectional and longitudinal analyses to examine both the prevalence and incidence of the disease using data from the Lifelines Cohort and Biobank Study. We hypothesize that having both a high GRS and a low SEP results in an excess risk for T2DM and that behavioral and clinical risk factors partly explain this interaction.
METHODS

Study Design and Sample
The study sample was derived from the Lifelines Cohort and Biobank Study (22) . Lifelines is a multidisciplinary prospective population-based cohort study examining the health and health-related behaviors of 167,729 persons living in the north of the Netherlands. Between November 2006 and December 2013, individuals were invited through their general practitioner or a family member, and there was an option for self-registration. The recruitment and collection of data have been described in detail elsewhere (22) .
For the present study, we used participants who were genotyped at baseline (n = 13,395) on whom phenotypic data were obtained from the baseline measurement, from two follow-up questionnaires after approximately 1.5 and 3 years, and from a physical follow-up measurement after 5 years. The selection and genotyping of this subsample have been described in detail elsewhere (23) with the only difference that we used 1000 Genomes imputation instead of HapMap. Lifelines was conducted according to the guidelines in the Declaration of Helsinki, and all procedures involving human subjects were approved by the medical ethics committee of the University Medical Center Groningen. Written informed consent was obtained from all participants.
Measures and Procedures
Type 2 Diabetes Mellitus
The presence of T2DM was determined at four measurement points. At baseline, T2DM was diagnosed as having a measured fasting plasma glucose (FPG) 7.0 mmol/L or greater (24) and/or a measured HbA1c of 6.5% or more (48 mmol/mol) (24) and/or recorded medication use (i.e., anatomical therapeutic chemical codes A10A and A10B) (25) and/or self-reported T2DM in combination with self-reported medication use. For the follow-up after 1.5 and 3 years, T2DM diagnosis was based on self-reported new onset of the disease. At the physical follow-up after 5 years, T2DM was diagnosed based on FPG, HbA1c, and self-reported disease. T2DM diagnosis, which does not include type 1 DM cases, and blood value measurements have been described in more detail elsewhere and are in line with previous studies that used Lifelines data. (26, 27) .
Socioeconomic Position SEP was measured as educational level at baseline. Educational level has been shown to be a good indicator to study socioeconomic health inequalities in the Netherlands (28) . In addition, the proportion of missing data is usually small compared with other indicators of SEP (29) . Educational level was measured according to the International Standard Classification of Education with a single-item question regarding the highest educational level achieved (30) . Educational level was categorized into low (no education, primary education, lower or preparatory vocational education, lower general secondary education), medium (intermediate vocational education or apprenticeship, higher general senior secondary education or preuniversity secondary education), and high SEP (higher vocational education, university), which is the standard categorization of educational level in the Netherlands (31).
Genetic Predisposition
To determine participants' genetic predisposition to T2DM, we selected SNPs from the most recent large meta-analysis of genome-wide association studies (GWAS) in European populations (32) supplemented with more recent findings from the same consortium (33) (34) (35) . Only SNPs with a p value of less than the genome-wide significance threshold (p < 5 Â 10 −8 ) were included. If two articles reported the same marker, the result with the smallest p value was selected. Furthermore, we tested for independence by correlating the allele dosages within Lifelines. If the pairwise r 2 value of two SNPs exceeded .1, we excluded the SNP with the least-significant p value. For each selected SNP, we collected the alleles, risk-allele frequency, odds ratio (OR), and p value. See Supplemental Table 1 (Supplemental Digital Content, http://links.lww.com/PSYMED/A441) for the selected SNPs (n = 63) and effect sizes.
Participants' genetic predisposition to T2DM was assessed by calculating a weighted GRS from ORs obtained from the previously mentioned GWAS. First, we log transformed the ORs to acquire a direct effect size for each SNP. For each SNP in each participant, we then multiplied the effect size with the number of risk alleles of that SNP. Adding up these values per participant for all 63 SNPs yields the weighted GRS of that participant. Because there are no clear cut-off points for defining low or high genetic risk, we created three equal groups (i.e., low, medium, or high genetic predisposition for T2DM). This allows for a possible biological gradient without losing too much power.
Behavioral and Clinical Risk Factors
Behavioral and clinical risk factors were measured at baseline and concerned smoking, alcohol consumption, physical activity, body mass index (BMI), waist circumference (WC), and hypertension. Smoking status was categorized as being a current smoker, ex-smoker, or never smoker (36) . Alcohol consumption was categorized into drinking 0 d/wk, drinking 0 to 1 d/wk, drinking more than 1 to 3 d/wk, and drinking more than 3 d/wk. Because information on the average number of units consumed on a drinking day was not available for half of our study sample (i.e., the question was not included in early versions of the questionnaire), we could not specify alcohol consumption any further. Physical activity was based on the number of days per week participants were active for at least half an hour (e.g., bicycle, odd jobs, exercise) and was categorized into being inactive (0-2 d/wk), moderately active (3-4 d/wk), or active (≥5 d/wk). BMI was calculated as weight (kilogram) divided by height (meter) squared and used as an index of general weight status. Participants were categorized as having underweight (BMI < 18.5), normal weight (BMI ≥18.5 to ≤24.9), overweight (BMI ≥25.0 to ≤29.9), or obesity (BMI ≥30.0) (37) . WC was measured to the nearest 0.5 centimeter and used as an index for abdominal obesity. Participants were categorized as not having abdominal obesity (WC <102 cm in males, WC <88 cm in females) and having abdominal obesity (WC ≥102 cm in males, WC ≥88 cm in females) (37) . Hypertension diagnosis was based on measured blood pressure and recorded medication use. A mean systolic and diastolic blood pressure were measured using an automatic blood pressure monitor (22) . Participants with a BP of greater than 140/90 mm Hg (38) , and participants with recorded antihypertensive medication (i.e., anatomical therapeutic chemical codes C02, C03, C07, C08, C09) (25) were categorized as hypertensive, as was previously done in Lifelines (26) . Clinical measurements were performed by trained research staff using standardized protocols and calibrated measuring equipment (22) .
Statistical Analyses
First, we created a variable in which we categorized participants into nine possible groups according to their GRS and SEP. We then described baseline characteristics concerning sociodemographic, behavioral, and clinical risk factors. We also calculated the overall baseline prevalence and 5-year incidence of T2DM.
Second, we assessed cross-sectional and longitudinal associations of GRS and SEP with T2DM using logistic regression models and Cox regression models, respectively. ORs and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for each category of GRS and SEP, with the reference category being low GRS and high SEP (39) . All analyses were adjusted for age, age squared, sex, and the first 10 principal component scores (PCs). Adjusting analyses for the first 10 PCs is common practice to correct for possible population stratification in studies using genotypic data (40) . In the longitudinal analysis, we excluded participants with T2DM at baseline. Effect modification of sex was examined by adding an interaction term to the cross-sectional and longitudinal models. Because no effect modification was observed in the cross-sectional (p = .65) or longitudinal (p = .61) models, analyses were not stratified by sex.
Third, we assessed the interaction of GRS and SEP regarding T2DM on the additive scale by calculating the relative excess risk due to interaction (RERI), both in cross-sectional and in longitudinal analyses. The RERI shows whether the risk for T2DM is larger than the sum of the separate risks when both risk factors are present. The additive scale has been shown to best fit the method for assessing biological interaction in previous studies (39, 41, 42) . Analyses were performed using the recommended syntax and Excel tool by Andersson et al. (43) . To gain further insight, we also examined associations between SEP and T2DM within categories of GRS and between GRS and T2DM within categories of SEP (39) .
Fourth, to examine whether behavioral and clinical risk factors explain the associations and interactions of GRS and SEP with T2DM, we adjusted the basic model stepwise for behavioral and clinical risk factors at baseline. In model 1, we adjusted for smoking status, alcohol consumption, and physical activity. In model 2, we added general weight status and abdominal obesity. In model 3, we included hypertension. Participants with missing data on clinical and behavioral risk factors were excluded from these analyses. In the final cross-sectional and longitudinal models, 13.0% and 11.7% had missing data, respectively. This was mainly due to missing data on physical activity (9.1% and 7.9%), smoking status (4.3% and 4.1%), and alcohol use (2.1% and 1.2%). Data on clinical risk factors was mostly complete (i.e., 7 [0.1%] and 6 [0.1%] missing values).
We performed two sensitivity analyses. First, we repeated the second and third step of the analyses using household income instead of educational level as indicator for SEP. Second, we repeated the second and third step of the analyses using quartiles instead of tertiles for the GRS.
Analyses were performed using STATA 13 (Stata Corp, College Station, TX).
RESULTS
Baseline Characteristics
In total, 13,027 and 11,756 participants were included in the crosssectional and longitudinal analyses, respectively (Supplemental Figure 1 , Supplemental Digital Content, http://links.lww.com/ PSYMED/A441). Baseline characteristics of the cross-sectional study sample are shown by GRS and SEP in Table 1 . Participants with a low SEP, regardless of GRS, tended to be older than participants with a medium or high SEP. They were also more often obese, smoker, and had a higher prevalence of hypertension compared with participants with a medium or high SEP. Baseline characteristics of the longitudinal study sample were essentially similar (Supplemental Table 2 , Supplemental Digital Content, http://links.lww.com/ PSYMED/A441). T2DM prevalence increased with an increasing GRS and decreasing SEP and was highest for participants with a high GRS and low SEP (8.2%) (Fig. 1) . T2DM incidence followed a similar pattern, but differences between categories were less pronounced. The median follow-up time for the longitudinal study sample was 57.0 months (25th-75th percentile = 47.0-68.0 months). The overall prevalence of T2DM was 3.9% at baseline, and the overall incidence during 5-year follow-up was 2.2%. Information about the distribution of the GRS is presented in Supplemental Table 3 and Supplemental Figure 2 
Associations and Interactions of GRS and SEP With T2DM
In the cross-sectional analyses, we found statistically significant associations for a high GRS with a low, medium, and high SEP and for having a medium GRS with medium or low SEP ( Table 2 ). The OR for T2DM was highest for participants with a high GRS and low SEP (OR = 3.84, 95% CI = 2.28-6.46). We found statistically significant interactions between a high GRS and a low SEP (RERI = 1.85, 95% CI = 0.65-3.05) and between a medium GRS and a low and medium SEP ( Table 2) . No interaction was observed between a high GRS and medium SEP.
In the longitudinal analyses, statistically significant associations of GRS and SEP with T2DM were observed for a high GRS with a low or medium SEP and a medium or low GRS in combination with a low SEP ( Table 2 ). The HR for T2DM was highest for participants with a high GRS and a low SEP (HR = 2.71, 95% CI = 1. 39-5.27) . No statistically significant interaction was found between GRS and SEP.
Stratified Analyses for T2DM Within Categories of GRS and SEP
The upper part of Table 3 shows the association of SEP with T2DM within categories of GRS. In the cross-sectional analyses, low and medium SEP were associated with increased odds for T2DM for participants with a medium and high GRS, but not for participants with a low GRS. In the longitudinal analyses, low and medium SEP were associated with T2DM for participants with a high GRS. Moreover, low SEP was associated with T2DM for participants with a low, but not medium, GRS.
The bottom part of Table 3 shows the association of GRS with T2DM within categories of SEP. In the cross-sectional analyses, a high GRS was associated with higher odds for T2DM across all FIGURE 1. Baseline prevalence and 5-year incidence of T2DM across socioeconomic groups per category of genetic risk score. b GRS = genetic risk score; SEP = socioeconomic position; T2DM = type 2 diabetes mellitus; OR = odds ratio; CI = confidence interval; RERI = relative excess risk due to interaction; HR = hazard ratio.
ORs/HRs are adjusted for age, age squared, sex, and PCs. a RERI T2DM for medium SEP.
b RERI T2DM for low SEP.
categories of SEP, whereas a medium GRS was associated with increased odds for T2DM in participants with a medium and low SEP. In the longitudinal analyses, a high or medium GRS was not associated with T2DM within categories of SEP.
The Role of Clinical and Behavioral Risk Factors in the Association and Interaction of GRS and SEP With T2DM
Clinical and behavioral risk factors partly explained the associations and interactions of GRS and SEP with T2DM in the crosssectional analyses (Table 4) . After their inclusion, a high GRS was still associated with T2DM across all categories of SEP. A statistically significant interaction between a high GRS and a low SEP was still observed after adjustment for smoking status, alcohol consumption, and physical activity (RERI = 1.20, 95% CI = 0.07-2.32) (model 1) but no longer after additional adjustment for weight status (model 2). In the longitudinal analyses, only a high GRS for participants with a medium SEP was still associated with T2DM after adjustment for all clinical and behavioral risk factors (HR = 2.37, 95% CI = 1.13-4.97) (model 3).
Sensitivity Analyses
The first sensitivity analysis showed that associations between SEP and T2DM were somewhat stronger when using household income as indicator for SEP (Supplemental Table 4 , Supplemental Digital Content, http://links.lww.com/PSYMED/A441). However, the interaction effect was smaller. The second sensitivity analysis showed that categorizing the GRS into quartiles yields very similar results (Supplemental Table 5 , Supplemental Digital Content, http://links.lww.com/PSYMED/A441). The point estimates for T2DM for those in the highest GRS quartile became a bit larger at the expense of precision.
DISCUSSION
In this study of more than 13,000 Dutch adults from the general population, we found in both cross-sectional and longitudinal analyses that participants with a high GRS and a low SEP had the OR = odds ratio; CI = confidence interval; HR = hazard ratio; SEP = socioeconomic position; T2DM = type 2 diabetes mellitus; GRS = genetic risk score.
ORs/HRs are adjusted for age, age squared, sex, and PCs.
Some categories in this table are similar to those in Table 2 , but ORs/HRs may slightly differ because these are result from within category analyses (i.e., different size of the sample being analyzed and therefore a slightly different correction for covariates). highest risk for T2DM compared with participants with a low GRS and a high SEP. In addition, a high GRS and a low SEP exacerbated each other's impact in cross-sectional but not in longitudinal analyses. Clinical and behavioral risk factors mostly explained the associations and interactions of a high GRS and a low SEP on T2DM.
A major strength of this study is that T2DM diagnosis, depending on the measurement point, was based on biological markers (FPG and HbA1c), on recorded medication use, and on self-reports in a population-based study sample. In addition, the clinical risk factors general obesity, abdominal obesity, and hypertension were measured by trained research staff. Finally, the GRS was based on the most recent GWAS findings in individuals from European ancestry including only SNPs that were genomewide significantly associated with T2DM. However, this study also has some limitations that warrant attention. The 5-year follow-up period (median = 57.0 months; 25th-75th percentile = 47.0-68.0 months) is relatively short for demonstrating interaction, maybe leading to an underestimation of the full effects. This was supported by a post hoc power calculation showing a power of 26.6% to detect interaction in the longitudinal analyses. Larger studies or studies pooling several data sets, with a longer follow-up period, are needed to compensate for the low incidence. We further had some missing data in the model adjusted for all clinical and behavioral risk factors, implying that their explanatory effect may be slightly larger in particular regarding alcohol consumption.
We demonstrated that a high GRS and a low SEP were separately associated with T2DM, which confirms findings from previous studies (6, (44) (45) (46) . We further showed that these risk factors exacerbated each other's impact on T2DM prevalence but not incidence. A similar result was recently found for family history of T2DM as indicator for genetic predisposition, although only for women (21) . In the longitudinal analyses, we did not find an interaction between a high GRS and low SEP, on top of their separate effect. This contrasts with previous findings that the effect of genetic risk on HbA1c levels is smaller among people with a higher educational level (15) . An explanation may be our shorter follow-up period (i.e., 5 years versus 18 years) and our younger study sample (i.e., M (SD) = 48.1(11.4) years versus 64% aged >65 [mean not presented]).
There were two noteworthy differences between the findings from the cross-sectional and longitudinal analyses. First, a high GRS was more strongly associated with T2DM in the cross-sectional than in the longitudinal analyses. The effect of a high GRS may have already come to expression cross-sectionally, while more time might be needed to lead to effects in the longer term. Second, although low SEP was not cross-sectionally associated with T2DM in participants with a low GRS, a strong association between low SEP and T2DM in participants with a low GRS was found in longitudinal analyses. This contradictory finding deserves attention in future studies because the cross-sectional results suggest that a weak genetic predisposition may buffer the negative effect of low SEP.
We found that the interaction between a high GRS and a low SEP was partly explained by clinical and behavioral risk factors. In general, most T2DM cases can be attributed to dietary habits, physical inactivity, smoking, alcohol consumption, and overweight or obesity (47, 48) , and previous studies have shown that these and other risk factors mediate the relationship between low SEP and T2DM (7) (8) (9) (10) . This may be due to underlying factors that are associated with low SEP, such as low health literacy (49) . Low health literacy has been shown to hamper the interpretation and translation of information about risk factors into healthy behavior (49). Low health literacy may then contribute largely to the development of diseases with a major behavioral component, such as T2DM.
Our findings regarding educational level and household income as indicators for SEP were largely similar. Results might differ somewhat in magnitude when other indicators of SEP are used (e.g., occupational status). However, it is likely that the main conclusions would be similar, because all indicators for SEP measure underlying social stratification (29) . For T2DM specifically, this is illustrated by a systematic review and meta-analysis on the relation between SEP and T2DM incidence (6) . This review showed that the relative risk for T2DM was similar for low educational level, low occupational status, and low income. In practical terms, in care settings, it is easier and will evoke less resistance to assess people's educational level than income, because income is often considered private information.
Findings from this study may have some important implications for clinical practice and research. Prevention and intervention strategies aimed at reducing T2DM incidence should target people with a strong genetic predisposition for the disease, especially in the context of a low SEP. This may regard genotyping or family history as its proxy as long as genotyping is not generally available (21, 50) . These strategies should address individual and contextual factors (51) . Individual factors should definitely include health behaviors such as physical inactivity and obesity (7, 8) and potentially contributing factors such as low health literacy (49) . Contextual factors should include, e.g., the built environment, which has shown to be important for the development of obesity (52), the most important risk factor for T2DM.
Our cross-sectional findings further suggest that low SEP does not have a detrimental effect regarding T2DM in case of a low GRS. This might imply that prevention measures do not need to target individuals with a low SEP and weak genetic predisposition, but evidently, this requires additional study. Future studies should also examine factors contributing to the interaction between strong genetic predisposition and low SEP, such as dietary habits and the physiologic response to chronic stress related to low SEP, because they may play an important role in T2DM etiology (11, 53) . Future research may also need to investigate the role of sleep behavior because several genes have been found to affect both sleep behavior and the risk for T2DM (54) . Finally, because our findings are based on people of European ancestry, future studies need to examine whether results are generalizable to other ethnic groups with a different genetic predisposition to T2DM (11) .
We conclude that the co-occurrence of a high GRS and low SEP is associated with T2DM prevalence and 5-year incidence. We further conclude that a high GRS and a low SEP exacerbate each other's impact regarding T2DM prevalence, but we could not replicate this finding for T2DM incidence. Finally, we conclude that clinical and behavioral risk factors mostly explained the associations and interactions of a high GRS and a low SEP on T2DM. The exacerbation by low SEP of T2DM risk in genetically predisposed people therefore deserves attention in prevention and community care.
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